Ha Dong - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Ha Dong

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Scientific Reports|October 20, 2020

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.

Life Sciences|November 8, 2011

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetesMi-Kyung Kim, Yu Na Chae, Ha Dong Kim, et al.

Bioorganic & Medicinal Chemistry Letters|May 17, 2011

Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetesHeung Jae Kim, Woo Young Kwak, Jong Pil Min, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Scientific Reports|October 20, 2020

A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.

Life Sciences|November 8, 2011

DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetesMi-Kyung Kim, Yu Na Chae, Ha Dong Kim, et al.

Bioorganic & Medicinal Chemistry Letters|May 17, 2011

Discovery of DA-1229: a potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetesHeung Jae Kim, Woo Young Kwak, Jong Pil Min, et al.

Pageof 2